Health Headlines

FDA probes diabetes drug metformin for carcinogen NDMA

The U.S. Food and Drug Administration and other healthcare regulators are investigating whether diabetes drug metformin had contaminations of a cancer-causing chemical that prompted a recall of a commonly used heartburn medication this year.

Top News Video

Top News